20.01.2013 Views

Financial Statements - Solvay

Financial Statements - Solvay

Financial Statements - Solvay

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

future) reacts with atmospheric<br />

oxygen in an electrochemical<br />

reaction (the reverse of electrolysis);<br />

developing hydrogen storage<br />

solutions by investing on the<br />

Conduit Ventures Fund (UK).<br />

In the fi eld of hydrogen-based<br />

energy production, <strong>Solvay</strong> Solexis is<br />

developing AQUIVION perfl uorinated<br />

proton exchange membranes<br />

for PEMFCs (Proton Exchange<br />

Membrane Fuel Cells).<br />

For its part, the SolviCore 50/50 joint<br />

venture with Umicore is developing<br />

and manufacturing on a pilot scale<br />

membrane-electrode assemblies<br />

(MEAs) that combine <strong>Solvay</strong>’s<br />

expertise in membrane polymers with<br />

Umicore’s in precious metals used as<br />

catalysts. SolviCore maintains close<br />

contacts with certain players in the<br />

hydrogen and fuel cells chain.<br />

At the end of 2008, <strong>Solvay</strong> invested<br />

GBP 1.25 million in ACAL Energy<br />

(UK), which is developing an original<br />

fuel cell concept in which the platinum<br />

cathode is replaced with a circulating<br />

of an aqueous solution of a more<br />

stable and less expensive liquid<br />

catalyst.<br />

The Nanotechnologies<br />

platform<br />

These technologies for structuring<br />

the infi nitely small have at times<br />

already led to specifi c products.<br />

Examples include the development<br />

and marketing of nanostructured<br />

fl uorinated polymers and the launch<br />

of NANOLIPANTHYL ® , a new<br />

formulation of an existing drug that<br />

facilitates assimilation.<br />

The platform was launched in mid-<br />

2008 with the mission of gathering,<br />

constructing and disseminating<br />

expertise in a multidisciplinary<br />

context, fi nding and supporting<br />

specifi c projects, and undertaking<br />

a scientifi c and technology watch in<br />

nanotechnologies. Four programs<br />

were activated in 2008.<br />

The Renewable Chemistry<br />

and Industrial Biotechnology<br />

platform<br />

This new platform has the mission<br />

of exploring <strong>Solvay</strong>’s development<br />

potential in these fi elds. It will also<br />

cover the different “renewable<br />

materials” chains. The fi rst concrete<br />

results in this area are the production<br />

of epichlorohydrin by the EPICEROL ®<br />

process and the project for a fi rst<br />

ethanol-based ethylene unit for PVC<br />

production in Brazil.<br />

For Renewable Chemistry, an initial<br />

series of partnerships were put<br />

together in 2008:<br />

membership in Europabio,<br />

the European Association for<br />

Bioindustries;<br />

participation in ACDV (Association<br />

Chimie du Végétal), a joint<br />

partnership in France between<br />

the UIC (Union des Industries<br />

Chimiques) and the corresponding<br />

agricultural industries;<br />

New Business Development<br />

participation in the BioHub program<br />

in France, which is subsidized by<br />

the AII (Agence de l’Innovation<br />

Industrielle);<br />

participation in the Eureka-labelled<br />

Halobios Plastici project, with<br />

French start-up SeaDev;<br />

investment in Capricorn Cleantech<br />

Fund, at Leuven (Belgium).<br />

47<br />

<strong>Solvay</strong> Global Annual Report 2008<br />

New Business Development

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!